US HB4966 | 2015-2016 | 114th Congress

Status

Sponsorship: Moderate Partisan Bill (Democrat 8-1)
Status: Introduced on April 15 2016 - 25% progression, died in committee
Action: 2016-04-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Preventing Superbugs and Protecting Patients Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization. The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Preventing Superbugs and Protecting Patients Act

Sponsors


History

DateChamberAction
2016-04-22HouseReferred to the Subcommittee on Health.
2016-04-15HouseReferred to the House Committee on Energy and Commerce.
2016-04-15HouseIntroduced in House

Same As/Similar To

SB2503 (Related) 2016-04-05 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.

Subjects


US Congress State Sources


feedback